DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has reported its financial results for second quarter 2021; the company also released a corporate and commercial update. Highlights of the report included total revenue of $5.3 million, which represents a 46% increase sequentially and a 194% year over year, a validated B2B expansion with new clients being secured in all B2B segments; patients on platform reaching 197,000; and B2B2C sales pipeline reaching more than $900 million. In addition, operational highlights included the acquisition of wayForward and the company’s expansion into the digital behavioral health market as well as the completion of four new employer client contracts, which are slated to bring in revenue for Dario in the Q3 2021. The company also finalized a global collaboration with Workplace Options, the largest independent provider of employee well-being solutions and announced that it has been chosen to provide remote patient monitoring services to Alabama Regional Medical Services and Coastal Family Health Center. “During the second quarter and subsequent period, we saw increasing demand for our integrated multi-condition digital therapeutics solution, driven in part by the expansion of our metabolic offering into musculoskeletal and pain conditions through the acquisition of Upright Technologies in February 2021 and into behavioral health through the acquisition of wayForward in June 2021,” said Dario CEO Erez Raphael in the press release. “We believe Dario’s offering is the most comprehensive, fully integrated, hyper-personalized digital therapeutics suite in the industry, as demonstrated by customer acceptance, and now market acceptance, as well as the fact that approximately two-thirds of our expanded sales pipeline is made of opportunities that include our complete chronic condition management platform. . . . At the same time, the execution of our long-term strategic operating plan resulted in several new employer clients, further penetration into the rapidly growing provider’s remote patient monitoring (“RPM”) market, and we believe that a health plan contract is imminent. Equally as important, Dario continues to on-board new patients efficiently and enrollment trends remain strong. We believe that this bodes well for new clients anticipated throughout the remainder of the third and fourth quarter this year.”
To view the full press release, visit https://ibn.fm/IpuGy
About DarioHealth Corp.
DarioHealth is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market, covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Dario’s next-generation, AI-powered, digital therapeutic platform supports more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions; intuitive, clinically proven digital tools; high-quality software; and coaching to help individuals improve health and sustain meaningful outcomes. Dario’s unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results. The company’s cross-functional team operates at the intersection of life sciences, behavioral science and software technology, utilizing a performance-based approach to improve users’ health. On the path to better health, Dario makes the right thing to do the easy thing to do. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.